سعر ريفاماش 1.5 مجم 2025

Rivamash (rivastigmine) 1.5 mg capsules, pack of 30 (3 strips), Mash Premiere, Egypt.

• Mild-to-moderate dementia of the Alzheimer's type.DailyMed (NLM)
• Mild-to-moderate dementia associated with Parkinson's disease.DailyMed (NLM)

• Known hypersensitivity to rivastigmine, other carbamate derivatives or formulation components.International label, same formulation · DailyMed (NLM)
• History of application-site reaction with rivastigmine patch suggestive of allergic contact dermatitis, without negative allergy testing.International label, same formulation · DailyMed (NLM)

• Gastrointestinal adverse reactions (nausea, vomiting, anorexia, weight loss) especially during titration; allergic dermatitis; cholinergic effects (bradycardia, GI bleeding risk, urinary obstruction, seizures, worsening extrapyramidal symptoms); may impair driving.International label, same formulation · DailyMed (NLM)

• MetoclopramideNot recommended together (additive extrapyramidal effects).DailyMed (NLM)
• Beta-blockersAdditive bradycardia.DailyMed (NLM)
• Cholinomimetic and anticholinergic drugsInterferes with anticholinergics; additive with cholinomimetics.DailyMed (NLM)

• No adequate data in pregnant women; no adverse embryo-fetal effects in animals at 2-4 times the maximum recommended human dose.International label, same formulation · DailyMed (NLM)
• No human milk data; rivastigmine and metabolites are excreted in rat milk.International label, same formulation · DailyMed (NLM)

English text not available for this section.